Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy

Maurizio Battaglia Parodi, Pierluigi Iacono, Marialucia Cascavilla, Ilaria Zucchiatti, Dimitrios Stylianos Kontadakis, Francesco Bandello

Research output: Contribution to journalArticlepeer-review

Abstract

PURPOSE. To assess the effects of intravitreal bevacizumab injections in the treatment of subfoveal choroidal neovascularization (CNV) associated with pattern dystrophy (PD) of the retinal pigment epithelium. METHODS. The study was a prospective, nonrandomized, openlabel, interventional clinical trial in which 12 patients were prospectively enrolled. Patients with a diagnosis of PD complicated by subfoveal CNV were considered for the study. All patients underwent a complete ophthalmic examination, including ETDRS visual acuity measurement, electroretinogram, electrooculogram, optical coherence tomography, and fluorescein angiography. The treatment protocol began with a loading dose of three consecutive injections at 1-month intervals, followed by injections administered as needed, according to OCT parameters and angiographic features observed during a 24-month follow-up period. The number of eyes with a visual acuity loss of fewer than 15 letters (

Original languageEnglish
Pages (from-to)4358-4361
Number of pages4
JournalInvestigative Ophthalmology and Visual Science
Volume51
Issue number9
DOIs
Publication statusPublished - Sep 2010

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Fingerprint Dive into the research topics of 'Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy'. Together they form a unique fingerprint.

Cite this